Micallef Jacob Vincent's Form 4 filing
Volitionrx Ltd (VNRX) · filed Dec 20, 2022
- Accession no.
- 0001477932-22-009423
- Filed
- Dec 20, 2022
- Trade date
- Dec 16-19, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $71.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Micallef Jacob VincentCIK 0001651671 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2022 | Common Stock | PPurchaseAcquired | +7,339 | $1.96 | +$14,384.44 | 163,392 | Direct | |
| Dec 19, 2022 | Common Stock | PPurchaseAcquired | +25,000 | $2.30 | +$57,500 | 188,392 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.